New-onset AFib after CABG | Key EP policies | PFA for ventricular tachycardia shows early potential

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.

Leaders from HRS and Heart Rhythm Advocates will take the stage to explore policy updates, advocacy goals for the future and much more.

Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.

More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.

Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.